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Abstract
Background:  High throughput microarray technologies have afforded the investigation of
genomes, epigenomes, and transcriptomes at unprecedented resolution. However, software
packages to handle, analyze, and visualize data from these multiple 'omics disciplines have not been
adequately developed.
Results: Here, we present SIGMA2, a system for the integrative genomic multi-dimensional analysis
of cancer genomes, epigenomes, and transcriptomes. Multi-dimensional datasets can be
simultaneously visualized and analyzed with respect to each dimension, allowing combinatorial
integration of the different assays belonging to the different 'omics.
Conclusion: The identification of genes altered at multiple levels such as copy number, loss of
heterozygosity (LOH), DNA methylation and the detection of consequential changes in gene
expression can be concertedly performed, establishing SIGMA2 as a novel tool to facilitate the high
throughput systems biology analysis of cancer.
Background
Multiple mechanisms of gene disruption have been
shown to be important in the development of cancer.
Genetic alterations (mutations, changes in gene dosage,
allele imbalance) and epigenetic alterations (changes in
DNA methylation and histone modification states) are
responsible for changing the expression of genes. High
throughput approaches have afforded the ability to inter-
rogate the genomic, epigenomic and gene expression
(transcriptomic) profiles at unprecedented resolution [1-
6]. However, a gene can be disrupted by one or by a com-
bination of mechanisms, therefore, investigation in a sin-
gle 'omics dimension (genomics, epigenomics, or
transcriptomics) alone cannot detect all disrupted genes
in a given tumor. Moreover, individual tumors may have
different patterns of gene disruption, by different mecha-
nisms for a given gene while achieving the same net effect
on phenotype. Hence, a multi-dimensional approach is
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required to identify the causal events at the DNA level and
understand their downstream consequences.
The current state of software for global profile comparison
typically focuses on analyzing and displaying data from a
single dimension, for example CGH Fusion (infoQuant
Ltd, London, UK) for DNA copy number profile analysis
and GeneSpring (Agilent Technologies, Santa Clara, CA,
USA) for gene expression profile analysis. Software for
integrative analysis have been restricted to working with
datasets derived from limited combination of technology
platforms (Table 1) [7-10]. Though different software can
analyze data generated from different platforms, the abil-
ity to perform meta-analysis using data from multiple
microarray platforms is limited to a small number of soft-
ware packages. Consequently, integrative analysis of can-
cer genomes typically involves no more than two types of
data, most commonly the integration of gene dosage and
gene expression data [11-16] and recently expanded to
integrating allelic information [17]. Software to perform
multi-dimensional analysis are therefore greatly in
demand.
Here, we present SIGMA2, a novel software package which
allows users to integrate data from the various 'omics dis-
ciplines such as genomics, epigenomics and transcriptom-
ics. Multi-dimensional datasets can be simultaneously
compared, analyzed and visualized with respect to indi-
vidual dimensions, allowing combinatorial integration of
the different assays belonging to the different 'omics. The
identification of genes altered at multiple levels such as
copy number, LOH, DNA methylation and the detection
of consequential changes in gene expression can be con-
certedly performed, establishing SIGMA2 as a tool to facil-
itate the high throughput systems biology analysis of
cancer. SIGMA2  is freely available for academic and
research use from our website, http://www.flintbox.com/
technology.asp?Page=3716.
Implementation
SIGMA2 is implemented in Java, and requires version 1.6+
of the runtime compiler. In addition, the statistical pack-
age R and database application MySQL are also required.
The java interface communicates with MySQL using a
JDBC connector and with R using the JRI package by JGR
(Figure 1). MySQL is used for data storage and querying
while R is used for the segmentation and statistical analy-
sis. All genomic coordinate information was obtained
from University of California Santa Cruz (UCSC) genome
databases [18].
Results and discussion
Look and feel of SIGMA2
The novel multi-dimensional 'omics data analysis soft-
ware SIGMA2 is built on the framework of a facile visuali-
zation tool called SIGMA, which can display alignment of
genomic data from a built-in static database [7]. The arse-
nal of functionalities introduced in SIGMA2 is shown in
Table 1.
Description of application scope and functionality
SIGMA2 is built to handle a variety of analysis techniques
typically used in the high-throughput study of cancer,
allowing the combinatorial integration of multiple 'omics
disciplines. The hierarchy, which underlies the program,
groups data into genome, epigenome, and transcriptome
is shown in Figure 2A and the overall functionality map is
given in Figure 2B and listed in Table 2. With each 'omics
Table 1: Features required for integrative analysis
Features required for integrative analysis Nexus CGH CGH Fusion ISA-CGH VAMP *CGH Analytics MD-SeeGH SIGMA SIGMA2
Built-in segmentation for array CGH 33 3 3 3 3 3
Consensus calling using multiple segmentation 
algorithms
3
Array platform-independent combined CGH analysis 33 3
Custom microarray data handling 33 3 3 3 3 3
Basic copy number and expression integration 33 3 3
Alignment and analysis of genetic and epigenetic data 33 3
Multi-dimensional visualization of genetic, epigenetic 
and gene expression data
3
Two group statistical comparison 33 33
Two group combinatorial gene dosage and gene 
expression comparison
3
Linking to external biological databases 3 3 33 3 3 33
Linking to external gene expression (GEOProfiles) 3
Context-based visualization of genome features 33 3 3 3
Conversion of data between different genome 
assemblies
33 3 3
Free for academic/research use 33 3 3 33BMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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dimension, data sets may be imported representing any of
the major types of biological measurements being
assayed, for example, (i) examining both DNA copy
number and LOH assays within the genomic bundle, (ii)
examining both DNA methylation and histone modifica-
tion status within the epigenomics bundle, and (iii) exam-
ining both gene expression profiles and microRNAs
expression assays within the transcriptomic bundle. Each
assay may branch into data sources from a multitude of
technology platforms.
Approach to integration between array platforms and 
assays
SIGMA2 treats all data in the context of genome position
based on the relevant human genome build using the
UCSC genome assemblies. An interval-based approach is
used to sample across different array platforms and assays
and data from each interval are merged together. Briefly,
this is done by querying data at fixed genomic intervals for
each platform and subsequently taking an average of the
measurements within each interval. The algorithm is
listed in Figure 3.
Format requirements of input data
Standard tab-delimited text files are used for the input of
data for all of the assay types. For genomic data, specifi-
cally array CGH, normalization is recommended using
external algorithms such as CGH-Norm  and  MANOR
[19,20]. Segmentation analysis can be performed within
SIGMA2, but results from external analysis can be
imported and used in the consensus calling feature. The
algorithms which can be called within SIGMA2 currently
include  DNACopy  and  GLAD  [21,22]. Multiple sample
batch importing is available to facilitate efficient loading
of datasets. To utilize this, the user must create an infor-
mation file which describes each sample in the dataset.
Formatting requirements of the information file are spec-
ified in the manual. Alternatively, for Affymetrix SNP
array analysis, data should also be pre-processed and nor-
malized using the appropriate software, such as CNAG
before importing into SIGMA2  [23]. Genotyping calls
should be made prior to importing, using the "AA", "AB"
and "BB" convention. If the genotype call does not exist,
"NC" must be specified. For epigenomic data, data from
affinity based-approaches (MeDIP [6] and ChIP [24])
should contain a value representing the level of enrich-
ment and the genomic coordinates for each spot. Simi-
larly, for bisulphite-based approaches [25], a percent of
converted CpGs should be provided along with the
genomic coordinates for each spot. Finally, for transcrip-
tome data, gene expression data from Affymetrix experi-
ments can be directly imported and processed as CEL files
and are normalized using the MAS 5.0 algorithm imple-
mented in the "affy" package of R. For any assay type, cus-
tom data can be imported whereby the user provides a
map of the platform based on the given genome build,
and the unique identifier for the map must be used for the
data generated from those experiments.
Main structural components of SIGMA2 Figure 1
Main structural components of SIGMA2. Data and genome mapping information is stored in the MySQL database. Seg-
mentation analysis using DNACopy and GLAD and statistical analysis is performed using R, with results stored in database. Java 
was used to program the application, specifically for the user interface and the different types of visualization. Base-pair posi-
tions and gene annotations are linked to other biological databases to facilitate further interrogation by the user.
MySQL
-Data storage
-Querying
R
-Segmenta on
-Sta s cal analysis
Java
-User interface
-Visualiza on
JGR / JRI
JDBC
RMySQL
Link to 
external 
resources
SIGMA2
Biological Databases
• PubMed
￿ OMIM
￿ NCBI Gene
￿ UCSC Genome Browser
￿ GEO Proﬁles
￿ Database of Genomic VariantsBMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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(A) Data hierarchy describing the relationship between platforms, assays and 'omics disciplines Figure 2
(A) Data hierarchy describing the relationship between platforms, assays and 'omics disciplines. (B) Functionality 
map of SIGMA2. List of the various functions and the output from that function that can be performed given the number of 
samples or sample groups and dimensions. Multiple sample analysis (single group and two group) are microarray platform inde-
pendent. Functions listed in boxes are in addition to those listed in the box preceding the arrows.
Combinatorial Integration
Genome Epigenome Transcriptome 
DNA Copy Number Allelic Imbalance (LOH) DNA Methyla on Histone 
modiﬁca on
Gene & MicroRNA
Expression
Omics
Assay
Platform BAC 
array CGH
Oligo 
array CGH
SNP 
Arrays
Microsatellite 
markers
SAGE Microarrays MeDIP -
array CGH
Bisulphite-
based 
methods
ChIP-on-
chip
Single sample
Mul ple samples (one group)
Mul ple samples (two groups)
Single Pla orm / 
Single Assay
Single ‘omics
(Mul ple assays)
A,B,C,Q,R,S D,E,H 
A,B,C,L,Q,R,S
A,B,C,L,M,Q,R,S
D,E,H
D,E,H
Combinatorial Integra on 
(Mul ple ‘omics)
F,G,O,P
F,G,I,J,K,O,P
F,G,I,J,K,N,O,P
A  Segmentation analysis for array CGH to identify regions of gain 
and loss 
B 
Moving average thresholding for affinity based approaches 
(MeDIP for DNA methylation, ChIP-on-chip for histone 
modification states) 
C  Regions of loss of heterozygosity (LOH) 
D  Regions of copy number change and LOH 
E  Regions of copy number neutrality and LOH (e.g. UPD) 
F  Regions of copy number AND methylation alteration ("two" hit) 
G  Regions of copy number OR methylation alteration 
(compensatory change with same net effect) 
H  Epigenetic interplay between DNA methylation and various 
modification states of histones 
I  Correlation of copy number and gene expression (dataset with 
matched copy number and expression profiles) 
J 
Statistical comparison of samples with copy number change 
versus without copy number change (dataset with matched copy 
number and expression profiles) using Mann Whitney U-test 
K  Correlation of DNA methylation and gene expression (dataset 
with matched DNA methylation and expression profiles) 
L  Identify recurrent changes (copy number alterations, common 
enrichment patterns [MeDIP, ChIP], regions of LOH)  
M  Statistical comparison of patters of recurrent changes between 
two groups using Fisher's exact test 
N 
Two-dimensional two-group comparisons (statistical comparison 
of expression profiles of genes in regions of difference identified 
by Fisher's exact comparison) 
O 
Identify "And" events between three or more DNA-based 
dimensions  (copy number, LOH, DNA methylation, histone 
modification states) 
P 
Identify "Or" events between three or more DNA-based 
dimensions  (copy number, LOH, DNA methylation, histone 
modification states) 
Q  Cancer gene discovery 
R  Lists of genes for systems/function/pathway analysis  
S 
Linking to public biological databases (PubMed, NCBI Gene, 
OMIM, NCBI GEO Profiles, UCSC Genome Browser, Database 
of Genomic Variants) 
A
BBMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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Description of user interface
The main user interface in SIGMA2 utilizes a tabbed win-
dow-pane which allows the user to open multiple visuali-
zations simultaneously (Figure 4). The left part of the
window manages the analyses and projects which belong
to the current user and button shortcuts for the main func-
Table 2: Summary of Input, analysis, output for each dimension
'Omics classification Assay(s) measured Input Functionality*** Output
Genomics Copy number Array CGH Segmentation
Direct thresholding
Moving average-based 
thresholding
Z-transformation of moving 
average
Whole genome visualization
Regions of gain and loss
Gene lists for further analysis
High-resolution karyogram 
images
Frequency histograms
Genomics LOH SNPs* LOH based on consecutive 
altered markers
Regions of LOH
Genomics LOH Microsatellite markers Same as above Same as above
Genomics Copy number, LOH Identify regions of uniparental 
disomy (UPD): LOH with no 
copy number change
Epigenomics DNA methylation MeDIP + array CGH Direct thresholding
Moving average-based 
thresholding
Z-transformation of moving 
average
Regions of enrichment and 
lack of methylation
Gene lists for further analysis
Epigenomics DNA methylation Bilsulphite-based Visualization against genome 
position
Thresholding of proportion of 
methylated CpG's
Epigenomics Histone modification states ChIP-on-chip Direct thresholding
Moving average-based 
thresholding
Z-transformation of moving 
average
Regions of enrichment and 
lack of enrichment
Gene lists for further analysis
Epigenomics DNA methylation, Histone 
modification states
Epigenetic interplay Regions of mutually exclusive 
change between chromatin 
state and DNA methylation
Transcriptomics Gene expression** Microarrays Heatmap visualization, 
clustering
Histograms
Statistical comparisons
Expression of genes of 
interested based on DNA 
analysis
Transcriptomics Gene expression** SAGE Heatmap visualization, 
clustering
Histograms
Statistical comparisons
Expression of genes of 
interested based on DNA 
analysis
Genomics, 
Transcriptomics
Copy number, Gene 
expression
Correlation analysis of copy 
number and expression
Statistical comparison of 
expression in regions of copy 
number difference 
(two group analysis)
Genes whose expression is 
strongly regulatd by copy 
number
p-values for associations
p-values for group 
comparison
Genomics, Epigenomics Copy number, DNA 
methylation
Identify regions of concerted 
change in BOTH copy number 
and methylation ("two-hit")
Identify regions with change in 
copy number OR DNA 
methylation
Genomics, Epigenomics LOH, DNA methylation Identify allele-specific 
methylation events
Regions of allele specific 
aberrant methylation
Genomics, Epigenomics, 
Transcriptomics
Copy number, LOH, DNA 
methylation, Histone 
modification Gene 
Expression
Identify co-ordinate genetic, 
epigenetic and gene 
expression changes
Genes altered at multiple 
levels
* Affymetrix and Illumina data must be pre-processed prior to import; ** functionality invoked in the context of genetic and epigenetic data 
analyses; ***aligned to genome features (Database of genomic variants, CpG Islands, microRNAs etc.)BMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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tionality are spread along the top of the window. Using an
example of an array CGH profile from the Agilent 244K
platform, we demonstrate the step-wise interrogation of a
region of interest [26]. Briefly, using the highlighting tool-
bar button, the user can select a region of interest and sub-
sequently, by clicking the right mouse button, the user can
search for annotated genes within the specified genomic
coordinates.
Analysis of data from a single assay type
The first, and most basic, level of analysis is from a single
assay type. For array CGH, multiple options for segmenta-
tion algorithms are available within the program and
results from externally run segmentation can be imported
as well. However, each segmentation algorithm has its
advantages and disadvantages depending on the type of
data used and the quality of data at hand. A unique feature
of SIGMA2 is the ability to take a consensus of multiple
algorithms using "And" or "Or" logic between algorithms.
Moreover, a level of consensus can be specified (Figure
5A). For example, if an experiment is analyzed using five
approaches, the user can select areas of gain and loss
which were detected by one algorithm, at least three algo-
rithms, all five algorithms, etc. For LOH, basic analysis
using the number of consecutive markers that exhibit
LOH is used to determine its status. Affinity-based
approaches for DNA methylation and histone modifica-
tion states or bead-based percentage of CpG island meth-
ylation is analyzed by either direct thresholding or z-
transform thresholding. For any of the different assay
types, when examining across a number of samples, a fre-
quency of alteration can be calculated and plotted.
For data from different array platforms, but assaying the
same biological measurement, the algorithm for integra-
tion is used to derive common data. This feature is most
applicable to DNA copy number data due to the number
of array CGH platforms. This allows for better utilization
of publicly available data and thus, increasing sample size
for statistical analysis. Similar to the multiple sample
analysis of data on the sample platform, a frequency of
altered states can be generated and plotted. Figure 5A
shows the concerted analysis of a sample profiled on the
Affymetrix 500K SNP array, Agilent 244K CGH array and
the whole genome tiling path BAC array (Figure 5B).
Analysis of data from multiple assays in a given 'omics 
dimension
Within a given 'omics dimension, multiple assay types can
be analyzed in combination. For example, it is useful to
investigate copy number and LOH and the interplay
between DNA methylation and different states of histone
modification. Typically, in regions of copy number loss,
LOH is also observed. However, LOH can also occur in
Algorithm for integrating between different array platforms Figure 3
Algorithm for integrating between different array platforms. Data for every platform is matched to genomic position. 
Subsequently, an interval-based approach is used to systematically query data for each interval. In this figure, the interval, k, is 
10 kb in size. By converting everything to genomic position, samples sets of the same disease type but on different array plat-
forms can be aggregated affording the user with additional statistical power.
numSamples<- number of samples
for chr <- 1: 24
k <- 10000
chrEnd<-length of chromosome
intervals <- chrEnd% k
data <- array[intervals, numSamples]
currentInterval<-0
for pos<-0, pos < chrEnd, pos+=k
for sampleNum <- 1:numSamples
data[currentInterval,sampleNum] <- data from sample for interval pos and pos+k*
end
currentInterval<-currentInterval+ 1
end
end
*if mul ple data points exist in the interval, an average is used.  If no data exists, blank is returned.  If it 
is array CGH data that is segmented, data is assumed to exist for any genomic posi on.BMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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regions which are copy number neutral, indicating a
change in allelic status which is not interpretable by one
dimension alone. Here, we show a sample for which copy
number and LOH information exists, a region of copy
number loss associated with LOH (Figure 6). In terms of
epigenetics, DNA methylation and states of histone meth-
ylation and acetylation have been known to be biologi-
cally relevant. With high throughput technologies
available to assay these dimensions, this type of analysis
will become more prevalent.
Combinatorial analysis of multiple 'omics dimensions – 
gene dosage and gene expression
The most common analysis of multiple 'omics dimen-
sions is the influence of the genome on the transcriptome.
A number of software packages have started to incorpo-
rate approaches to examining gene dosage and gene
expression [8,9,27]. In SIGMA2, there are multiple func-
tionalities which allow the user to link DNA copy number
to gene expression. For a single group of samples, with
matching DNA copy number and gene expression pro-
Description of the SIGMA2 user interface using a single sample visualization as an example Figure 4
Description of the SIGMA2 user interface using a single sample visualization as an example. (A) Customizable 
toolbar with shortcut buttons, (B) Project/Analysis tree to track work within and between sessions, (C) Main display area using 
tab-based navigation, (D) Information console and (E) Genome features tracks. Here, a copy number change is displayed in the 
context of CpG islands (red), microRNAs (orange) and regions annotated in the database of genomic variants (blue).
A
B
D
C
E
Search for genes, 
link to databasesBMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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files, the user can determine associations through two
main options: a) using a correlation-based approach, cor-
relating the log ratios with the normalized gene expres-
sion intensities and b) using a statistical-based approach
comparing the expression in samples with copy number
changes against those without copy number change utiliz-
ing the Mann Whitney U test, analogous to approaches
taken in previous studies [27]. Spearman, Kendall or Pear-
son correlation coefficients can be calculated for option
a). Similarly, this functionality is also available for corre-
lating epigenetic profiles and gene expression.
In addition to single group analysis, two-dimensional
genome/transcriptome analysis can be applied to two-
group comparison analysis. For example, if patterns of
copy number alterations are compared between two
groups and a particular region is more frequently gained
in one group than another, the expression data can subse-
quently compared between the groups of sample to deter-
mine if there is an association between gene dosage and
gene expression. That is, we would expect the group with
more frequent copy number gain to have higher expres-
sion than the other group. Notably, this functionality
does not require both copy number and expression data
to exist for the same sample, but allows the user to select
an independent dataset for expression data comparisons
(Figure 7).
Group comparison analysis – single 'omics dimension
Finally, for two groups of samples, the user can compare
the distribution of changes between two groups to deter-
mine if the patterns are statistically different using a
Fisher's Exact test. For DNA copy number, it is the distri-
bution of gain and losses; for DNA methylation or histone
modification states, the proportion of samples that meet
the threshold of enrichment for each group (low or high);
and for LOH, proportion of samples with LOH for a
region for each group.
Group comparison analysis – integrating multiple 'omics 
dimensions
This type of analysis can be performed with a single sam-
ple or multiple samples, thus allowing combinatorial
("and") analysis for large datasets. In addition, the user
can also identify "or" events, where a change in any of the
dimensions can be flagged. This is more important in
(A) Consensus calling using multiple algorithms Figure 5
(A) Consensus calling using multiple algorithms. Multiple algorithms (and different parameters) can be 
selected to analyze a given array CGH sample and this can be defined for each array platform independently as 
each platform may have exhibit different noise and ratio response characteristics. (B) Heterogeneous array analy-
sis using data from multiple array CGH platforms. Sample from the Agilent 244K, Affymetrix SNP 500K and whole genome 
BAC array were segmented to define areas of gain and loss. Subsequently, the results were aggregated into a frequency histo-
gram plot showing the common areas of gain and loss across the three samples.
AB
Affymetrix 
SNP 500K
Agilent
244K CGH
BCCA
WGTP 32KBMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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multi-sample datasets as one dimension may not capture
complex alterations of a particular region.
Multi-dimensional analysis of a breast cancer genome
Using the breast cancer cell line HCC2218, we show the
integration of genomic, epigenomic, and transcriptomic
data. Interestingly, when we examine the ERBB2 gene on
chromosome 17, we show concurrent amplification,
LOH, loss of methylation and drastic increase in gene
expression (Figure 8). ERBB2 has shown to be an impor-
tant gene in breast cancer development and therapeutic
intervention. This demonstrates the value in integrating
multiple dimensions to understand complex alteration
patterns in disease samples where multiple causes can
lead to a single effect.
Exporting data and results
High resolution images can be exported for all types of
visualizations in SIGMA2. Histogram plots of gene expres-
sion, heatmaps with clustering of gene expression, karyo-
gram plots and frequency histogram plots are the main
types of visualization available. Frequency histogram data
which is used to generate the plots can also be exported.
Integrated plots with data plotted serially or overlaid are
also available for analysis involving multiple genomic
and epigenomic dimensions. Genes which are obtained
Parallel visualization and analysis of the copy number and genotype profiles of the breast cancer cell line HCC2218 Figure 6
Parallel visualization and analysis of the copy number and genotype profiles of the breast cancer cell line 
HCC2218. Genotype profile of the matching normal blood lymphoblast line (HCC2218BL) is also provided to define regions 
of LOH. DNA copy number profile was generated on the BCCA whole genome tiling path BAC array and genotype profiles 
are from the Affymetrix SNP 10K array [28]. This region of chromosome arm 3q has a defined segmental copy number loss 
and the boundary of the change is evident from the LOH profile. In the genotype profile, the horizontal blue lines indicate a 
SNP transition from heterozygous in normal to homozygous in the tumor, indicating LOH.
LOH Copy Number
HCC2218 HCC2218 HCC2218BLBMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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from the conjunctive (And) and disjunctive (Or) multi-
dimensional analysis can be exported with their status.
Results of statistical analysis such as Fisher's exact compar-
isons and U-test comparisons of gene expression can be
exported against annotate gene lists based on user-speci-
fied human genome builds. Currently, April 2003 (hg15),
May 2004 (hg17) and March 2006 (hg18) are the availa-
ble genome builds [18]. As new builds are released, sup-
A two-group two dimensional comparison of 37 NSCLC and 16 SCLC cancer cell lines Figure 7
A two-group two dimensional comparison of 37 NSCLC and 16 SCLC cancer cell lines. First, segmentation analysis 
is performed to delineate gains and losses in each sample. Next, a statistical comparison of the distribution of gains and losses 
between the two groups is done using the Fisher's exact test. (A) Using the interactive search, one of the regions of difference 
identified is on chromosome 7, with a NSCLC and SCLC sample aligned next to each other. The NSCLC has a clear segmental 
gain of that region, with the SCLC not having the gain. The right-most graph is a frequency plot summary of two sample sets 
(NSCLC and SCLC). NSCLC is color-coded in red while SCLC in green, and the overlap appears in yellow. The frequency of 
chromosome arm 7p gain is higher in the red group. (B) A heatmap is shown representing 15 NSCLC and 15 SCLC gene 
expression profiles, of the specific genes in the region highlighted in yellow. (C) When examining gene expression data of EGFR 
specifically, a gene in this region, we can see that the expression is drastically higher in NSCLC vs. SCLC, as predicted by the 
higher frequency of gain in NSCLC vs. SCLC of that region. Gene expression data are represented as log2 of the normalized 
intensities.
NSCLC SCLC
AB C
Multi-dimensional perspective of chromosome 17 of the HCC2218 breast cancer cell line Figure 8
Multi-dimensional perspective of chromosome 17 of the HCC2218 breast cancer cell line. Copy number, LOH, 
and DNA methylation, and profiling identifies an amplification of ERBB2 coinciding with allelic imbalance and loss of methyla-
tion. When examining the gene expression, the expression of HCC2218 is significantly higher than a panel of normal luminal 
and myoepithelial cell lines [29].
HCC2218 Myoepithelial Luminal
DNA Copy Number Allelic imbalance (LOH) DNA MethylationBMC Bioinformatics 2008, 9:422 http://www.biomedcentral.com/1471-2105/9/422
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port for those builds will be available. Finally, data from
multi-platform integration can be exported based on
based pair position for additional external analysis if nec-
essary.
Conclusion
With the increase in high-throughput data covering mul-
tiple dimensions of the genome, epigenome and tran-
scriptome, the approaches and tools to analyze this data
must advance accordingly to handle, analyze and inter-
pret this data in an integrated manner. SIGMA2 meets
these requirements and provides the framework for the
incorporation of data from future approaches and tech-
nologies. Specifically, with the movement from array to
sequence-based technologies, the ability to assimilate
sequence data with the various 'omics data sets will
become a future requirement of software packages.
Availability and requirements
Project name: SIGMA2
Operating system(s): Java SE V.1.6+, R Project V.2.5+,
Windows XP or Vista
License: Free for academic and research use; commercial
users please contact
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